AI offers cure for ‘needle in a haystack’ enzyme selection process
A new artificial intelligence (AI) tool could streamline the complex and time-consuming process of designing and selecting the best performing enzymes used in therapeutics for the treatment of genetic and autoimmune disorders including diabetes. Described as searching for a ‘needle in a haystack’, researchers typically use a labour intensive, trial-and-error approach to engineer enzymes for […]
AI offers cure for ‘needle in a haystack’ enzyme selection process Read More »









